ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NTLA Intellia Therapeutics Inc

23.80
-0.08 (-0.34%)
09 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Intellia Therapeutics Inc NTLA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.08 -0.34% 23.80 08:40:15
개장가 저가 고가 종가 전일 종가
23.38 22.756 23.64 23.00 23.88
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202420:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
29/04/202420:30GLOBEIntellia Therapeutics to Present Updated Data from Phase 1/2..
18/03/202420:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/02/202421:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/02/202407:17EDGAR2Form 8-K - Current report
23/02/202406:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/02/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202421:45EDGAR2Form 8-K - Current report
22/02/202421:30GLOBEIntellia Therapeutics Announces Fourth Quarter and Full-Year..
15/02/202421:30BWIntellia Therapeutics and ReCode Therapeutics Announce..
14/02/202421:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
02/02/202406:05EDGAR2Form 8-K - Current report
01/02/202407:00GLOBEIntellia Therapeutics Announces Publication of Positive..
30/01/202406:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/01/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:05EDGAR2Form 144 - Report of proposed sale of securities
06/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:07EDGAR2Form 8-K - Current report
05/01/202406:01GLOBEIntellia Therapeutics Highlights its Three-Year Strategic..
04/01/202407:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202321:00EDGAR2Form 8-K - Current report
24/11/202323:30EDGAR2Form S-3ASR - Automatic shelf registration statement of..
14/11/202321:30GLOBEIntellia Therapeutics Receives European Union Orphan Drug..
10/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:45EDGAR2Form 8-K - Current report
09/11/202321:30GLOBEIntellia Therapeutics Announces Third Quarter 2023 Financial..
03/11/202305:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202320:11EDGAR2Form 8-K - Current report
02/11/202320:00GLOBEIntellia Presents New Interim Data from the Ongoing Phase 1..
26/10/202320:30GLOBEIntellia Therapeutics to Present Updated Data from Ongoing..
18/10/202320:30EDGAR2Form 8-K - Current report
18/10/202320:00GLOBEIntellia Therapeutics Announces FDA Clearance of..
13/10/202321:38GLOBEIntellia Therapeutics Receives Priority Medicines (PRIME)..
03/10/202320:19EDGAR2Form 8-K - Current report
03/10/202320:00GLOBERegeneron and Intellia Announce Expanded Research..
04/08/202305:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202320:45EDGAR2Form 8-K - Current report
03/08/202320:30GLOBEIntellia Therapeutics Announces Second Quarter 2023..
03/08/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/08/202305:45EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

Delayed Upgrade Clock